UNSPSC 85704011: Revision of nonautologous tissue substitute in left tibia, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in left tibia, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QWH4KZ

UNSPSC 85704011 Revision of nonautologous tissue substitute in left tibia, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity under state and local procurement. The code's scope nominally names a specific orthopedic surgical procedure — revision of synthetic or donor tissue in the tibia using minimally invasive technique — yet the recent state and local opportunities posted under this code do not solicit orthopedic tissue products or surgical implants. Instead, the tagged opportunities cover medical evaluation services, pharmacy benefit management, occupational health surveillance, youth detention healthcare, and temporary clinical staffing — none of which align with the code's surgical-device or tissue-substitute scope. This mismatch signals that the code as currently indexed does not reflect active state and local procurement demand for orthopedic revision procedures, tissue products, or related surgical supplies.

The six recent opportunities span Arizona (Phoenix Fire and Police pension boards' medical evaluation services), California (City of Long Beach surgical benefits network and Santa Clara County temporary clinical staffing), Florida (Collier County pharmacy benefit management), Washington (Washington State Ferries occupational health), and Texas (Harris County juvenile detention healthcare) — a geographically dispersed set of purchases that underscores the tagging misalignment. No issuing body appears more than once under this code in the recent block, and no opportunity name, scope, or evaluation criterion relates to nonautologous tissue substitutes or tibial revision surgery. The code's assignment to these opportunities appears administrative rather than substantive. State and local procurement professionals evaluating this code should not expect to find active demand for orthopedic surgical implants, tissue products, or revision procedures under the current indexing.